Cargando…
Outcomes of Adjuvant Therapy for Stage IA Serous Endometrial Cancer
Purpose: Serous adenocarcinoma is a rare, aggressive histologic subtype of endometrial cancer with a high rate of recurrence and a poor prognosis. The optimal adjuvant treatment for early-stage patients is unclear. Our objective was to evaluate the outcomes of stage IA serous endometrial cancers onl...
Autores principales: | Donovan, Elysia, Reade, Clare J, Eiriksson, Lua R, Pond, Gregory R, Arora, Nikita, Elit, Lorraine, Memon, Sadaf, Voruganti, Sachi, Patel, Maltibehn, Jimenez, Waldo, John, Mazurka, Kong, Iwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267614/ https://www.ncbi.nlm.nih.gov/pubmed/30524915 http://dx.doi.org/10.7759/cureus.3387 |
Ejemplares similares
-
Bilateral Serous Retinal Detachment in Pregnancy
por: Phang, Daniel Sen Kai, et al.
Publicado: (2022) -
Role of Neoadjuvant Chemotherapy in Ovarian Serous Cancer Followed by Debulking
por: Chauhan, Sonali, et al.
Publicado: (2022) -
Complete Laparoscopic Ovarian Cystectomy of Giant Ovarian Serous Cystadenoma
por: Prasad, Indira, et al.
Publicado: (2023) -
Fertility-Preserving Surgery of Borderline Serous Ovarian Tumors: A Case Report
por: Mohapatra, Ipsita, et al.
Publicado: (2022) -
The Impact of Adjuvant Management Strategies on Outcomes in Women With Early Stage Uterine Serous Carcinoma
por: Cook, Andrew, et al.
Publicado: (2021)